Jie Lei
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- Cancer Genomics and Diagnostics 4
- Immunology top 10%
- Immune cells in cancer 6
-
- Cancer Immunotherapy and Biomarkers 5
-
- Single-cell and spatial transcriptomics 4
- Epigenetics and DNA Methylation 4
- Dermatology top 10%
-
- Lung Cancer Diagnosis and Treatment 8
- Lung Cancer Treatments and Mutations 5
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- International Journal of Surgery (4 papers)Cell Death and Disease (3 papers)FEBS Journal (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jie Lei
50 papers receiving 940 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 223
- Immunology 311
- Oncology 203
- Molecular Biology 474
- Dermatology 50
Countries citing papers authored by Jie Lei
This map shows the geographic impact of Jie Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Lei more than expected).
Fields of papers citing papers by Jie Lei
This network shows the impact of papers produced by Jie Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Lei. The network helps show where Jie Lei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jie Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 60 | |
| 10 | 2021 | 36 | |
| 11 | 2020 | 40 | |
| 12 | 2019 | 22 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 46 | |
| 15 | 2017 | 18 | |
| 16 | 2017 | 0 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 10 | |
| 19 | 2014 | 11 | |
| 20 | 2012 | 96 |
About Jie Lei
Jie Lei is a scholar working on Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 948 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (8 papers), Immune cells in cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Single-cell and spatial transcriptomics (4 papers), Cancer Genomics and Diagnostics (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (223 citations), Immunology (311 citations) and Oncology (203 citations). Jie Lei has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Gang Wang, Erle Dang, Shuai Shao, Jianfei Zhu, Tao Jiang, Hui Fang, Tianyu Cao, Yanlu Xiong, Hongxi Zhao and Jun Wang. Their work appears in journals such as International Journal of Surgery, Cell Death and Disease, FEBS Journal, Journal of Surgical Research and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.